je.st
news
Tag: questions
You've Got Recycling Questions, We've Got Answers! (Part Three)
2015-07-30 10:55:00| Waste Age
This is the third part of a series that provide answers by industry experts to questions you have about recycling. In this edition Harvey Gershman, Michele Nestor, Albe Zakes and Eric Herbert talk about the average monthly recycling costs, market development and the challenges for mixed waste processing. read more
Tags: part
three
questions
answers
Dear Monty: Home seller questions listing agent tactics
2015-07-29 09:38:28| Real Estate - Topix.net
Reader question: Hi, Monty, I read your articles regularly and find them very helpful and now have a query myself. Our Realtor called us for permission not to present offers below asking price; we agreed, but I don't understand it.
Tags: home
questions
listing
agent
Fiat Chrysler settlement raises questions for dealers, drivers
2015-07-28 04:16:46| Auto Dealers - Topix.net
The U.S. auto safety watchdog, toughening its stance against manufacturer defects, announces a record $105 million in fines against Fiat Chrysler Automobiles over lapses in safety recalls involving millions of vehicles. The U.S. auto safety watchdog, toughening its stance against manufacturer defects, announces a record $105 million in fines against Fiat Chrysler Automobiles over lapses in safety recalls involving millions of vehicles.
Tags: questions
drivers
dealers
settlement
You've Got Recycling Questions, We've Got Answers! (Part Two)
2015-07-23 10:38:00| Waste Age
This is the second part of a series that provide answers by industry experts to questions you have about recycling. In this edition Bill Moore, Michele Nestor, Albe Zakes, Eric Herbert and Bruce Walker talk about the strategy of not charging for recycling, organic waste and single-stream collection and developing a secondary raw material market. read more
Tags: two
part
questions
answers
Biotech ETFs: 3 Questions For IShares Investing Expert
2015-07-23 06:55:09| Biotech - Topix.net
TF investors in biotechnology stocks may be rattled by the nose-dive of the first heavyweight out of the earnings gate. , the $10 billion biotech exchange traded fund, has lost 0.8% in the past three trading sessions as 's reports this week, IBD spoke to Tushar Yadava, an iShares investment strategist, on whether the biotech sector has room to run: Tushar Yadava: Biotech investors entering for the first time are likely doing so in search of consistent growth - something the sector has delivered for a few years running.
Tags: questions
expert
investing
biotech
Sites : [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] next »